Efficacy and safety of a modified vaccinia Ankara (MVA) vectored plague vaccine in mice.

Vaccine
Joseph BrewooJorge E Osorio

Abstract

The efficacy and safety of plague vaccines based on the modified vaccinia Ankara (MVA) viral vector was evaluated. MVA recombinants were constructed expressing Yersinia pestis antigens under the translational control of the encephalomyocarditis virus (EMCV) internal ribosomal entry site (IRES) and/or fused to the tissue plasminogen activator (tPA) secretory signal. A MVA/Y. pestis recombinant that expressed a truncated version of the low-calcium response V antigen (MVA/IRES/tPA/V(307)), conferred significant protection (87.5-100%) against intranasal or intraperitoneal challenge with CO92 (encapsulated) or Java 9 (non-encapsulated) strains of Y. pestis, respectively. In contrast, a MVA/Y. pestis recombinant that expressed the full-length V antigen provided only 37.5% protection against challenge with CO92 or Java 9 strains, respectively. Interestingly, a MVA/Y. pestis recombinant that expressed the capsular protein (F1) did not elicit significant antibody titers but still conferred 50% and 25% protection against CO92 or Java 9 challenge, respectively. The MVA/Y. pestis recombinant viruses did not demonstrate any mortality or morbidity in SCID mice. Based on their safety and efficacy in mice, these MVA/Y. pestis recombinants are ...Continue Reading

References

Apr 1, 1995·Journal of Medical Microbiology·I G DrozdovV I Kravchenko
Sep 4, 1997·The New England Journal of Medicine·M GalimandP Courvalin
Dec 10, 1997·Journal of Wildlife Diseases·S H Anderson, E S Williams
Apr 21, 1999·Clinical and Experimental Immunology·E D WilliamsonR W Titball
May 12, 2000·JAMA : the Journal of the American Medical Association·T V InglesbyK Tonat
Jun 15, 2000·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·K L GageJ D Stein
Dec 29, 2000·Transactions of the Royal Society of Tropical Medicine and Hygiene·J M GabastouA Ruiz
Jul 18, 2001·Vaccine·R W Titball, E D Williamson
Feb 21, 2002·Infection and Immunity·Yidong DuAke Forsberg
Feb 1, 2003·Vaccine·Jorge E OsorioDan T Stinchcomb
Jun 15, 1957·Nature·T W BURROWS
Jun 4, 2004·Expert Opinion on Biological Therapy·Richard W Titball, E Diane Williamson
Jun 19, 2004·Journal of Drug Targeting·Jorge E OsorioDan T Stinchcomb
Nov 25, 2004·Current Opinion in Biotechnology·Ingo DrexlerGerd Sutter
Feb 26, 2005·Infection and Immunity·Alexander V PhilipovskiySusan C Straley
May 24, 2005·Infection and Immunity·E D WilliamsonM Irving
Jul 26, 2005·Infection and Immunity·Katie A OverheimOlaf Schneewind
Oct 22, 2005·Infection and Immunity·Michelle A ParentStephen T Smiley
Jun 3, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Richard HarropMiles W Carroll
Aug 18, 2006·Vaccine·Shengqiang LiFilip Dubovsky
Sep 29, 2006·Antimicrobial Agents and Chemotherapy·Marc GalimandPatrice Courvalin
Mar 23, 2007·Clinical and Vaccine Immunology : CVI·J BashawS Welkos
Mar 8, 2008·Expert Review of Vaccines·Stephen T Smiley
Mar 19, 2008·Infection and Immunity·Lauriane E QueneeOlaf Schneewind
Oct 30, 2008·Journal of Wildlife Diseases·Tonie E RockeJorge E Osorio

❮ Previous
Next ❯

Citations

Jun 15, 2011·Applied Microbiology and Biotechnology·Jason A RosenzweigAshok K Chopra
Sep 16, 2011·Journal of Infection in Developing Countries·Wei SunRoy Curtiss
Jul 25, 2014·PLoS Neglected Tropical Diseases·James Weger-LucarelliJorge E Osorio
Apr 9, 2015·Viruses·Lucas Sánchez-SampedroMariano Esteban
Nov 1, 2012·Emerging Microbes & Infections·Valentina A Feodorova, Vladimir L Motin
Dec 27, 2016·Frontiers in Immunology·Shailendra Kumar Verma, Urmil Tuteja

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.